The companies’ memorandum of understanding outlines the transfer of Stereax millimeter-scale battery manufacturing to Cirtec’s production facility in Lowell, Massachusetts.
The deal reinforces Brooklyn Park, Minnesota-based Cirtec’s activities in system-level miniaturization for the medical device industry, the companies said in a news release.
“With over 20 years of experience in the design, development and manufacturing of medical devices, Cirtec is uniquely poised to work with Ilika in bringing its Stereax battery technology to market,” Cirtec CEO Brian Highley said in the news release. “We believe this collaboration fits right into our strengths and expands upon our mission to vertically integrate our capabilities to support our offerings to the implantable and wearable device markets,”
U.K.-based Ilika’s focus remains centered on developing advanced technology and IP licensing for the micro batteries in support of Cirtec’s manufacturing and commercialization efforts.
“Our partnership with Cirtec reinforces a pathway towards commercialization of our Stereax battery technology,” Ilika CEO Graeme Purdy said in the release. “Cirtec brings a wealth of manufacturing experience and a strong track record of successful product commercialization in the medical device industry to our partnership.”